BBIO icon

BridgeBio Pharma

95 hedge funds and large institutions have $3.28B invested in BridgeBio Pharma in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+7
Holders Change %
+7.95%
% of All Funds
2.1%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.13%
New
25
Increased
42
Reduced
16
Closed
16
Calls
$11.3M
Puts
$3.19M
Net Calls
+$8.08M
Net Calls Change
+$8.08M
Name Holding Trade Value Shares
Change
Shares
Change %
WC
101
Wexford Capital
Florida
-$526K -15,000 Closed
M&T Bank
102
M&T Bank
New York
-$245K -7,000 Closed
Neuberger Berman Group
103
Neuberger Berman Group
New York
-$228K -6,500 Closed
SO
104
STRS Ohio
Ohio
-$206K -5,900 Closed
PWMAG
105
Pinnacle Wealth Management Advisory Group
New Jersey
-$203K -5,800 Closed
PA
106
Pinnacle Associates
New York
-$203K -5,800 Closed
NIT
107
NumerixS Investment Technologies
British Columbia, Canada
-$56K -1,600 Closed
TRCT
108
Tower Research Capital (TRC)
New York
-$38K -1,097 Closed
EW
109
Evoke Wealth
California
-$1.89K -54 Closed
TWA
110
TCI Wealth Advisors
Arizona
-$1K -28 Closed